A comparative study of two antimicrobial/anti-inflammatory formulations in the treatment of canine otitis externa

Veterinary Dermatology

Volumn 16, Issue 5, 2005, Pages 299-307

  Rougier, Sandrine ^a   Borell, Daniela ^a   Pheulpin, Sandrine ^a   Woehrlé, Frédérique ^a   Boisramé, Bernard ^a  

^a Vetoquinol SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CLOTRIMAZOLE; DEXAMETHASONE; MARBOFLOXACIN; QUINOLONE DERIVATIVE; TOPICAL ANTIINFECTIVE AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOG DISEASE; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECT; EXTERNAL OTITIS; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PATHOLOGY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; ANTI-INFLAMMATORY AGENTS; CLOTRIMAZOLE; DEXAMETHASONE; DOG DISEASES; DOGS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MALE; MICROBIAL SENSITIVITY TESTS; OTITIS EXTERNA; QUINOLONES; TREATMENT OUTCOME;

CANIS FAMILIARIS; ENTEROBACTERIACEAE; MALASSEZIA; PSEUDOMONAS; STAPHYLOCOCCUS;

EID: 27744600132     PISSN: 09594493     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2005.00465.x     Document Type: Article

References (40)

1. August JR. Otitis externa: a disease of multifactorial aetiology. Veterinary Clinics of North America: Small Animal Practice 1988; 18: 731-42.
2. Carlotti DN. Diagnosis and medical treatment of otitis externa in dogs and cats. Journal of Small Animal Practice 1991; 32: 394-400.
3. Jacobson LS. Diagnosis and medical treatment of otitis externa in the dog and cat. Journal of the South African Veterinary Association 2002; 73: 162-70.
4. Little C. Medical treatment of otitis externa in the dog and cat. In Practice 1996; 18: 66-71.
5. Murphy KM. A review of techniques for the investigation of otitis externa and otitis media. Clinical Techniques in Small Animal Practice 2001; 16: 236-41.
6. Morris DO. Medical therapy of otitis externa and otitis media. Veterinary Clinics of North America: Small Animal Practice 2004; 34: 541-55.
7. Brummett RE, Harris RF, Lindgren JA. Detection of ototoxicity from drugs applied topically to the middle ear space. Laryngoscope 1976; 86: 1177-87.
8. Kucers A, Crowe SM, Grayson ML et al. Polymyxins. In: The Use of Antibiotics - a Clinical Review of Antibacterial, Antifungal and Antiviral Drugs, 5th edn. Oxford: Butterworth-Heinemann, 1998: 667-75.
9. Angus JC. Otic cytology in health and disease. Veterinary Clinics of North America: Small Animal Practice 2004; 34: 411-24.
10. Scott SW, Miller WH Jr, Griffin CE. External ear disease. In: Kirk RH, Muller GH eds. Muller and Kirk's Small Animal Dermatology, 5th edn. Philadelphia: WB. Saunders, 1995: 970-89.
11. Bryskier A. Fluoroquinolones. In: Antibiotiques, Agents Antibactériens et Antifongiques. Paris: Ellipses, 1999: 71-3.
12. Prescott JF, Desmond Baggot J, Walker RD. Fluoroquinolones. In: Antimicrobial Therapy in Veterinary Medicine, 3rd edn. Iowa: Iowa State University Press/Ames, 2000: 315-38.
13. Meunier D, Acar JF, Martel JL et al. Seven-year survey of susceptibility to marbofloxacin of bovine strains isolates from eight European countries. International Journal of Antimicrobial Agents 2004; 24: 268-78.
14. Meunier D, Acar JF, Martel JL et al. A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets. International Journal of Antimicrobial Agents 2004; 24: 592-8.
15. Russel PT, Church CA, Jinn TH et al. Effects of common topical otic preparations on the morphology of isolated cochlear outer hair cells. Acta Oto-Laryngologica 2001; 121: 135-9.
16. Kiss G, Radvanyi S, Szigeti G. New combination for the therapy of canine otitis externa. I. Microbiology of otitis externa. Journal of Small Animal Practice 1997; 38: 51-6.
17. Lorenzini R, Mercantini R, De Bernardis F. In vitro sensitivity of Malassezia spp. to various antimycotics. Drugs Under Experimental and Clinical Research 1985; 11: 393-5.
18. Schmidt A. In vitro activity of climbazole, clotrimazole and silver-sulphadiazine against isolates of Malassezia pachydermatis. Zentralblatt für Veterinärmedizin. Reihe B. [Journal of Veterinary Medicine. Series B] 1997; 44: 193-7.
19. Logas D. Appropriate use of glucocorticoids in otitis externa. In: Bonagura JD ed. Kirk's Current Veterinary Therapy XIII. Small Animal Practice. Philadelphia: WB. Saunders, 2000: 585-6.
20. National Committee for Clinical Laboratory Standards (NCCLS). M2-A6 Performance Standards for Antimicrobial Disk Susceptibility Test, 6th edn. vol. 17, no. 1. 1997.
21. Studdert VP, Hughes KL. A clinical trial of a topical preparation of miconazole, polymyxin and prednisolone in the treatment of otitis externa in dogs. Australian Veterinary Journal 1991; 68: 193-5.
22. Cester CC, Schneider M, Toutain PL. Comparative kinetics of two orally administered fluoroquinolones in dog: enrofloxacin versus marbofloxacin. Revue de Médecine Vétérinaire 1996; 147: 703-16.
23. Heinen E. Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after oral administration. Journal of Veterinary Pharmacology and Therapeutics 2002; 25: 1-5.
24. Schentag JJ, Gilliland KK, Paladino JA. What have we learned from pharmacokinetic and pharmakodynamic theories? Clinical Infectious Diseases 2001; 32: S39-46.
25. Jones RN, Milazzo J, Seidlin M. Ofloxacin otic solution for treatment of otitis externa in children and adults. Archives of Otolaryngology - Head and Neck Surgery 1997; 123: 1193-200.
26. Gates GA. Safety of ofloxacin otic and other ototopical treatments in animal models and in humans. Pediatric Infectious Disease Journal 2001; 20: 104-7, 120-2.
27. Ruben RJ. Efficacy of ofloxacin and other otic preparations for otitis externa. Pediatric Infectious Disease Journal 2001; 20: 108-10, 120-2.
28. Gotthelf LN. Diagnosis and treatment of otitis media in dogs and cats. Veterinary Clinics of North America: Small Animal Practice 2004; 34: 469-87.
29. McKeever PJ. Otitis externa. Compendium 1996; 18: 759-72.
30. Logas DB. Diseases of the ear canal. Veterinary Clinics of North America: Small Animal Practice 1994; 24: 905-19.
31. Sander R. Otitis externa: a practical guide to treatment and prevention. American Family Physician 2001; 63: 927-36, 941-2.
32. Foster AP, De Boer DJ. The role of Pseudomonas in canine ear disease. Compendium 1998; 20: 909-19.
33. Thornsberry C. The in vitro antibacterial activity of quinolones: a review. In: Kuhlmann J, Dalhoff A, Zeiler HJ eds. Quinolone Antibacterials, vol. 127. Heidelberg: Springer, 1998: 167-78.
34. Uchida Y, Nakade T, Kitazawa K. Clinico-microbiological study of the normal and otitic external ear canals in dogs and cats. Nippon Juigaku Zasshi 1990; 52: 415-17.
35. Crespo MJ, Abarca ML, Cabanes FJ. Occurrence of Malassezia spp. in the external ear canals of dogs and cats with and without otitis externa. Medical Mycology 2002; 40: 115-21.
36. Rosser EJ. Causes of otitis externa. Veterinary Clinics of North America: Small Animal Practice 2004; 34: 459-68.
37. Simpson KL, Markham A. Ofloxacin otic solution. Drugs 1999; 58: 509-31.
38. Lilenbaum W, Vears M, Blum E et al. Antimicrobial susceptibility of staphylococci isolated from otitis externa in dogs. Letters in Applied Microbiology 2000; 31: 42-5.
39. Wai TK, Tong MC. A benefit-risk assessment of ofloxacin otic solution in ear infection. Drugs Safety 2003; 26: 405-20.
40. Jang CH, Park SY. Emergence of ciprofloxacin-resistant Pseudomonas in pediatric otitis media. International Journal of Pediatric Otorhinolaryngology 2003; 67: 313-16.